Orofaciodigital syndrome type 2

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2751OMIM:252100Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Orofaciodigital syndrome type 2 (OFD2), also known as Mohr syndrome, is a rare genetic disorder characterized by abnormalities of the mouth (oral), face (facial), and fingers and toes (digital). It belongs to the broader group of orofaciodigital syndromes but is distinguished by its autosomal recessive inheritance pattern and specific clinical features. Key oral findings include a lobulated or bifid tongue, midline cleft of the upper lip, cleft palate, and accessory frenula. Facial features may include a broad nasal root, frontal bossing, and midline cleft lip. Digital abnormalities are prominent and include bilateral polydactyly (extra fingers or toes), particularly postaxial polydactyly of the hands and feet, as well as brachydactyly (short digits) and syndactyly (fused digits). Some patients may also exhibit conductive hearing loss, which is an important distinguishing feature from other OFD subtypes. Mild intellectual disability has been reported in some cases but is not a consistent finding. Additional features may include episodic neuromuscular disturbances and, in some cases, midline brain abnormalities. There is no cure for OFD syndrome type 2, and management is symptomatic and supportive. Treatment typically involves a multidisciplinary approach including surgical correction of cleft lip and palate, removal or correction of extra digits, speech therapy, hearing aids or surgical intervention for hearing loss, and dental care. Regular developmental monitoring is recommended, particularly in early childhood. Genetic counseling is advised for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormal oral frenulum morphologyHP:0000190Tongue nodulesHP:0000199Hypoplasia of teethHP:0000685Preaxial foot polydactylyHP:0001841Y-shaped metacarpalsHP:0006042Agenesis of central incisorHP:0006289Broad halluxHP:0010055Broad first metatarsalHP:0010068Complete duplication of hallux phalanxHP:0010100Bifid tongueHP:0010297Hamartoma of tongueHP:0011802Submucous cleft soft palateHP:0011819Finger clinodactylyHP:0040019Velopharyngeal insufficiencyHP:0000220
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Orofaciodigital syndrome type 2.

View clinical trials →

No actively recruiting trials found for Orofaciodigital syndrome type 2 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Orofaciodigital syndrome type 2 community →

No specialists are currently listed for Orofaciodigital syndrome type 2.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Orofaciodigital syndrome type 2.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Orofaciodigital syndrome type 2Forum →

No community posts yet. Be the first to share your experience with Orofaciodigital syndrome type 2.

Start the conversation →

Latest news about Orofaciodigital syndrome type 2

No recent news articles for Orofaciodigital syndrome type 2.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Orofaciodigital syndrome type 2

What is Orofaciodigital syndrome type 2?

Orofaciodigital syndrome type 2 (OFD2), also known as Mohr syndrome, is a rare genetic disorder characterized by abnormalities of the mouth (oral), face (facial), and fingers and toes (digital). It belongs to the broader group of orofaciodigital syndromes but is distinguished by its autosomal recessive inheritance pattern and specific clinical features. Key oral findings include a lobulated or bifid tongue, midline cleft of the upper lip, cleft palate, and accessory frenula. Facial features may include a broad nasal root, frontal bossing, and midline cleft lip. Digital abnormalities are promi

How is Orofaciodigital syndrome type 2 inherited?

Orofaciodigital syndrome type 2 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Orofaciodigital syndrome type 2 typically begin?

Typical onset of Orofaciodigital syndrome type 2 is neonatal. Age of onset can vary across affected individuals.